Jan. 25, 2012
HOUSTON—Children’s Memorial Hermann Hospital and Cord Blood Registry® (CBR) will undertake the first FDA-approved, Phase I safety study on the use of cord blood to restore hearing in babies who have sustained hearing loss post-natally. The year-long study, which will involve 10 patients, ages 6 weeks to 18 months, will use stem cells taken from each child’s own stored umbilical